Journal list Promote Sponsor
verified SJR 1,038 · Q2 • database Scopus / SJR & Web of Science indexed
International Journal of Psychiatry in Clinical Practice
United Kingdom · Informa Healthcare
workspace_premium Q2 — Psychiatry and Mental Health lock Subscription

International Journal of Psychiatry in Clinical Practice

International Journal of Psychiatry in Clinical Practice is a journal indexed in SJR in Psychiatry and Mental Health with an H index of 47. It has a price of 2395 €. It has an SJR impact factor of 1,038 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 1,038.

ISSN: 1365-1501
Publisher: Informa Healthcare
Category: Psychiatry and Mental Health
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Portal NPD menu_book Guidelines NPD
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
1,038 Q2
H-index 47
Acceptance rate pie_chart
33%
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
2.395 € Subscription
Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,038

H-index

47

Docs (year)

26

Docs 3y

154

Total refs

1316

Cites 3y

459

Citable 3y

141

Cites/Doc 2y

3

Ref/Doc

50.62

Immediate OA

2395 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Can we identify the factors influencing the burden on family members of patients with schizophrenia?

View more

Ventricular measurements in computed tomography of responders and non-responders to donepezil in the treatment of Alzheimer's disease

View more

Dissociative identity disorder (DID) in Japan: A forensic case report and the recent increase in reports of DID

View more

Discharge prescribing practices: Comparing a research ward to general treatment wards

View more

Diagnostic approaches to borderline personality and their relationship to self-harm behavior

View more

Depression therapy: Future prospects

View more

Depression comorbid with anxiety or medical illness: The role of paroxetine

View more

Delusional misidentification secondary to perceptual abnormality: An unusual case of Capgras syndrome

View more

Comparative efficacy of antidepressants on anxiety features in depression: A meta-analysis of double-blind studies of imipramine and moclobemide against placebo

View more

Comorbidity

View more

Clozapine-induced concordant agranulocytosis in monozygotic twins

View more

Clinical experience with olanzapine in the course of post-operative delirium associated with psychosis in geriatric patients: A report of three cases

View more
SHOW MORE ARTICLES

Cardiovascular reflexes during treatment of social phobia with moclobemide

View more

A common dementia in a rare disease

View more

Caffeine: The forgotten variable

View more

Atypical antipsychotics in the elderly

View more

Antidepressants: pharmacological profile and clinical consequences

View more

Anabolic steroid misuse: How much should we know?

View more

Alice in Wonderland' syndrome as a precursor of delusional misidentification syndromes

View more

Acute antidepressant response to fluoxetine and sertraline in psychiatric outpatients with psychomotor agitation

View more

Acute akathisia and sodium valproate

View more

A preliminary study of patients on repeat prescriptions of opioid and non-opioid analgesics

View more

A patient who changed my practice: The case for patient-based evidence versus trial-based evidence

View more

A naturalistic study on the criteria of choice of second-generation antidepressants: A comparison of venlafaxine and SSRIs in depressed inpatients

View more

FAQs